EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Artificial intelligence applications in microbiota-gut-brain axis research: Implications for Alzheimer's disease

Simone Lista iD, Enzo Emanuele iD, Miroslava Cuperlovic-Culf, Adam Mahdi, Vikas Singh, Susana López-Ortiz iD, Kayvan Khoramipour, María Merino-País iD, Piercarlo Minoretti iD, Giusy Ylenia Cisale, Amanda Heslegrave, Camillo Imbimbo iD und 5 weitere

Journal of Alzheimer’s Disease · 29.10.2026

DOI: 10.1177/13872877261500124 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 29.10.2026. Verfasst von Simone Lista und 16 weiteren Autor:innen. Beteiligte Einrichtung: i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain. Die Arbeit nennt 146 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alterations in the gut microbiota (GM) are increasingly implicated in Alzheimer's disease (AD) pathogenesis through the microbiota-gut-brain axis (MGBA), influencing neuroinflammation, amyloid-β deposition, and tau aggregation. The inherent complexity of microbiota data necessitates artificial intelligence (AI) and machine learning (ML) to identify novel biomarkers and therapeutic targets. In this narrative review, we examined AI applications in AD-related GM research, including metataxonomic and metagenomic approaches. AI methods facilitate microbial signature identification and enterotype characterization associated with AD progression, enable multi-omics integration clarifying molecular pathways linking GM dysbiosis to neurodegeneration, support predictive modeling for early AD detection, and inform personalized MGBA-targeted interventions. Employed techniques include classical ML (e.g., random forests) for taxonomic classification, deep learning (e.g., neural networks) for complex pattern recognition, and explainable AI for identifying key bacterial taxa and metabolic functions. Significant challenges persist regarding methodological standardization, larger longitudinal cohorts, and ethical considerations in clinical applications. Future priorities include developing interpretable models, integrating longitudinal multi-omics data to establish causality, and validating AI-derived insights for precision AD prevention and treatment. AI uniquely enables high-dimensional, non-linear analyses that advance understanding of microbiome-brain interactions, though clinical translation requires rigorous validation and interdisciplinary collaboration.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseartificial intelligencegut microbiotamachine learningmetagenomicsmetataxonomics

Autor:innen und Institutionen

  • i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain.
  • Scientific Directorate, 2E Science, Pavia, Italy.
  • Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Ottawa Institute of Systems Biology, University Ottawa, Ottawa, ON, Canada.
  • Digital Technologies Research Centre, National Research Council Canada, Ottawa, ON, Canada.
  • Department of Biostatistics & Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA.

ORCID-Profile: Simone Lista, Enzo Emanuele, Susana López-Ortiz, María Merino-País, Piercarlo Minoretti, Camillo Imbimbo, Giulia Maria Sancesario, Bruno P Imbimbo

Zitieren

APA

Lista, S., Emanuele, E., Cuperlovic-Culf, M., Mahdi, A., Singh, V., López-Ortiz, S., Khoramipour, K., Merino-País, M., Minoretti, P., Cisale, G. Y., Heslegrave, A., Imbimbo, C., Sancesario, G. M., Bendlin, B. B., Imbimbo, B. P., Zetterberg, H., & Santos-Lozano, A. (2026). Artificial intelligence applications in microbiota-gut-brain axis research: Implications for Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261500124

Vancouver

Lista S, Emanuele E, Cuperlovic-Culf M, Mahdi A, Singh V, López-Ortiz S, et al. Artificial intelligence applications in microbiota-gut-brain axis research: Implications for Alzheimer's disease. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261500124

BibTeX
@article{Lista2026,
  author = {Lista, Simone and Emanuele, Enzo and Cuperlovic-Culf, Miroslava and Mahdi, Adam and Singh, Vikas and López-Ortiz, Susana and Khoramipour, Kayvan and Merino-País, María and Minoretti, Piercarlo and Cisale, Giusy Ylenia and Heslegrave, Amanda and Imbimbo, Camillo and Sancesario, Giulia Maria and Bendlin, Barbara B and Imbimbo, Bruno P and Zetterberg, Henrik and Santos-Lozano, Alejandro},
  title = {Artificial intelligence applications in microbiota-gut-brain axis research: Implications for Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261500124}
}
Kostenlos starten →